FDA approves Merck & Co's combination child vaccine
9th Sep 2005, 02:03 GMT
The FDA has given its approval for Merck's combination vaccination Proquad, for simultaneous vaccination against measles, mumps, rubella and chickenpox in children 12 months to 12 years of age.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol